In 1985, a group of kindergarten teachers in Quebec got together at the end of the school year and filled out a series of detailed questionnaires about their students. They rated the five- and six-year-olds’ behaviour on a three-point scale on measures of attentiveness (Does this child have their head in the clouds all the… Read More »
The Food and Drug Administration (FDA) has approved Emgality (galcanezumab-gnlm; Lilly) for injection for the treatment of episodic cluster headache in adults. The approval was based on the results from a phase 3 double-blind, placebo-controlled trial that included 106 patients diagnosed with episodic cluster headaches. Patients were randomized to receive either once-monthly Emgality 300mg administered… Read More »
Numerous studies have shown that aerobic exercise can improve cognition in seniors, but a small new study finds that vigorous workouts boost thinking skills in younger adults as well. After a six-month aerobic regimen, adults aged 20 to 67 showed improvements in executive function – the cognitive processes important for reasoning, planning and problem solving… Read More »
For years, taking a daily aspirin was believed to be one of the easiest ways to protect long-term health. But the bottom line on aspirin has recently gotten more complicated. Some research finds that aspirin can potentially reduce the risk of heart attacks and cancer, and some suggests that aspirin’s possible side effects, such as… Read More »